Pregled bibliografske jedinice broj: 1046309
Protein phosphatase inhibition by okadaic acid treatment of neuroblastoma SH-SY5Y cells induces expression of high molecular weight phospho-tau- immunoreactive proteins
Protein phosphatase inhibition by okadaic acid treatment of neuroblastoma SH-SY5Y cells induces expression of high molecular weight phospho-tau- immunoreactive proteins // Neurologia Croatica. 2018 ; 67 (Suppl. 3)
Novigrad, Hrvatska, 2018. str. 52-52 (poster, domaća recenzija, prošireni sažetak, znanstveni)
CROSBI ID: 1046309 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Protein phosphatase inhibition by okadaic acid
treatment of neuroblastoma SH-SY5Y cells induces
expression of high molecular weight phospho-tau-
immunoreactive proteins
Autori
Boban, Mirta ; Babić Leko, Mirjana ; Miškić, Terezija ; Šimić, Goran
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, prošireni sažetak, znanstveni
Izvornik
Neurologia Croatica. 2018 ; 67 (Suppl. 3)
/ - , 2018, 52-52
Skup
Croatian Congress on Alzheimer’s Disease (CROCAD-18)
Mjesto i datum
Novigrad, Hrvatska, 03.10.2018. - 06.10.2018
Vrsta sudjelovanja
Poster
Vrsta recenzije
Domaća recenzija
Ključne riječi
Alzheimer's disease ; neurodegeneration ; cell culture ; SH-SY5Y ; okadaic acid ; oligomerization ; phosphorylation ; protein phosphatase ; tau protein ; immunoblot
Sažetak
A key feature of Alzheimer’s disease (AD) is aggregation of microtubule-associated protein tau in the neurofibrillary tangles (NFT) in the brain. NFT tau is characterized by abnormally high phosphorylation, which may result from the upregulated activity of protein kinases and downregulation of protein phosphatases. To investigate tau under the condition of protein phosphatase impairment, we treated neuroblastoma SH-SY5Y cells with okadaic acid (OA), an inhibitor of protein phosphatases and analyzed total cell lysates with phospho-tau and total tau antibodies using immunoblot. In addition to the well- described 50-65 kDa tau isoforms, we observed that both undifferentiated and retinoic acid- and brain derived neurotropic factor-differentiated SH-SY5Y cells treated with OA express high molecular weight protein species immunoreactive with anti- tau-pS202 and -pS396 antibodies. The apparent molecular weight of 100 kDa indicated a possibility of tau oligomer. In support, high molecular weight tau immunoreactive proteins (HMW- TIP) were detected in a heat-stable fraction. However, we were unable to detect HMW-TIP using several anti-total tau antibodies, including a polyclonal anti-tau antibody. This could be due to protein truncation or epitope masking within the oligomer, or a possibility that HMW-TIP represents a tau-unrelated protein. DC11 antibody, which has been reported to recognize specific form of truncated tau, showed a pattern distinct from that of HMW-TIPs. Our biochemical characterization showed that HMW-TIP were stable under reducing conditions and in the presence of strong denaturing agents urea and guanidine, as well as upon alkaline phosphatase treatment. In conclusion, we show that protein phosphatase inhibition by okadaic acid induces the appearance of HMW-TIP, which may represent tau oligomer or tau cross-reactive phospho-proteins.
Izvorni jezik
Engleski
Znanstvena područja
Biologija, Temeljne medicinske znanosti, Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
--IP-2014-09-9730 - Hiperfosforilacija, agregacija i transsinaptički prijenos tau proteina u Alzheimerovoj bolesti: analiza likvora i ispitivanje potencijalnih neuroprotektivnih spojeva (ALZTAUPROTECT) (Šimić, Goran) ( CroRIS)
Ustanove:
Medicinski fakultet, Zagreb